Episodes
Thursday Apr 04, 2019
E36: Baricitinib for SLE
Thursday Apr 04, 2019
Thursday Apr 04, 2019
This week I discuss the phase 2 trial on baricitinib in SLE. Though it's early times (and the total flop of rituxan in ME/CFS recently can attest to this), this was a large phase 2 and I'm hopeful it carries through to the ongoing phase 3 trials. Follow me on twitter and find all the papers / links at my new landing page, ebrheum.com!
Version: 20240731
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.